Editorial comments: Focus on pharmacological management

Gianfranco Parati; Géza Hálasz; Massimo Piepoli

doi:10.1093/eurjpc/zwac222

Abstract

1 min read

This special issue is dedicated to several topics related to the pharmacological management of cardiovascular (CV) risk factors in both primary and secondary prevention. In particular, the role in controlling high blood pressure and lipid has been investigated in different settings.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

USE OF COMBINATION TREATMENT IN HYPERTENSION MANAGEMENT AND ITS ASSOCIATION WITH HYPERTENSION CONTROL

Alessandro Croce, Grzegorz Bilo, Martino F. Pengo, Francesca Gorini, F. Amato, Richard Sucapuca, Débora Rosa, Gianfranco Parati

Article2011

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

Pascal Vranckx, Eric Boersma, Scot Garg, Marco Valgimigli, Gerrit‐Anne van Es, Dick Goedhart, Patrick W. Serruys

EuroIntervention

Article2022

Impact of Dietary Fats on Cardiovascular Disease with a Specific Focus on Omega-3 Fatty Acids

Aldo Maggioni, Giuseppe Poli, Pier Mannuccio Mannucci

Article2010

Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?

Claire Vesin, Pilar Galán, Benoît Gautier, Sébastien Czernichow, Serge Hercberg, Jacques Blacher

Article2013

Stress management and dietary counseling in hypertensive patients: a pilot study of additional effect

Alexia Katsarou, Marios M. Vryonis, Athanase D. Protogerou, Evangelos C. Alexopoulos, Apostolos Achimastos, Dimitrios Papadogiannis, George Chrousos, Christina Darviri